Covered recipient · General Payments record
AJMAL MASOOD GILANI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$731.73
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $309.52 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $69.37 | 3 |
| Lundbeck LLC | $61.89 | 2 |
| Neurelis, Inc. | $38.49 | 2 |
| Lilly USA, LLC | $27.78 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $27.26 | 1 |
| Alexion Pharmaceuticals, Inc. | $23.32 | 1 |
| Avanos Medical | $20.27 | 1 |
| Teva Pharmaceuticals USA, Inc. | $15.33 | 1 |
| PFIZER INC. | $13.52 | 1 |
| ERMI Inc. | $12.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.04 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103796212 | CMS |
| ABBVIE INC. | $20.39 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103796214 | CMS |
| ABBVIE INC. | $26.94 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103796216 | CMS |
| Alexion Pharmaceuticals, Inc. | $23.32 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093933201 | CMS |
| Avanos Medical | $20.27 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149305845 | CMS |
| Boston Scientific Corporation | $27.26 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092357952 | CMS |
| ERMI Inc. | $12.29 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142351700 | CMS |
| Lilly USA, LLC | $13.08 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136012333 | CMS |
| Lilly USA, LLC | $14.70 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136011439 | CMS |
| Lundbeck LLC | $33.04 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145918741 | CMS |
| Lundbeck LLC | $28.85 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145918743 | CMS |
| Neurelis, Inc. | $19.94 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145642110 | CMS |
| Neurelis, Inc. | $18.55 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145642112 | CMS |
| PFIZER INC. | $13.52 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131185297 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.33 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151534093 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.